Related Experiment Video
Updated: Jun 18, 2025
09:48
Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
2.6K
Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes
Muhammad Abdul-Ghani1, Pietro Maffei2, Ralph Anthony DeFronzo1
1Diabetes Division, UT Health, San Antonio, TX, USA.
The Lancet. Diabetes & Endocrinology
|August 4, 2024
Summary
Glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss but don't normalize insulin sensitivity in type 2 diabetes. New direct insulin-sensitizing drugs are needed to complement GLP-1 therapies for better diabetes management.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Glucagon-like peptide-1 (GLP-1) receptor agonists are widely used for type 2 diabetes, offering weight loss, improved beta-cell function, and cardiovascular benefits.
- Despite efficacy, GLP-1 receptor agonists do not fully normalize insulin sensitivity in patients with type 2 diabetes and obesity.
- Long-term impacts of GLP-1 receptor agonists on muscle mass, frailty, and bone density require further investigation.
Purpose of the Study:
- To highlight the limitations of current GLP-1 receptor agonist therapy in addressing insulin resistance in type 2 diabetes.
- To identify the unmet need for potent, direct insulin-sensitizing agents in combination therapy for type 2 diabetes.
- To discuss the role of insulin resistance in type 2 diabetes and cardiovascular disease pathogenesis.
Main Methods:
- Review of existing literature on GLP-1 receptor agonists and insulin sensitivity.
- Analysis of the mechanisms of action for insulin-sensitizing drugs.
- Discussion of the therapeutic gap in managing insulin resistance in type 2 diabetes.
Main Results:
- GLP-1 receptor agonists improve insulin sensitivity primarily through weight reduction, not direct action.
- Thiazolidinediones are the only direct insulin-sensitizing drugs but have limited use due to side effects.
- Insulin resistance is a key factor in type 2 diabetes and atherosclerotic cardiovascular disease development.
Conclusions:
- A significant unmet need exists for novel, potent insulin-sensitizing drugs for type 2 diabetes management.
- Combination therapy with GLP-1 receptor agonists and direct insulin sensitizers could improve patient outcomes.
- Further research into direct insulin-sensitizing agents is crucial for advancing type 2 diabetes treatment.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
68.1K
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
9.7K
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
01:36Carbohydrate Metabolism
10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K
01:15Diabetes: Management and Pharmacotherapy
247
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
247
01:22Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
01:20Pathophysiology of Diabetes
911
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
911
01:15Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521